Kumiai Chemical Bundle
Who Really Controls Kumiai Chemical?
Unraveling the Kumiai Chemical SWOT Analysis reveals more than just its products; it exposes the core of its influence. Understanding the Kumiai Chemical Company ownership is crucial for investors, competitors, and anyone seeking to understand the future of the agrochemical giant. Knowing who owns Kumiai Chemical offers insights into its strategic direction and long-term goals.
This deep dive into Kumiai Chemical Company ownership explores its Kumiai Chemical history, tracing its evolution from its founding in 1949 to its current status as a publicly listed entity on the Tokyo Stock Exchange. We'll examine the Kumiai Chemical parent company and its major stakeholders, providing a comprehensive overview of the company's ownership structure and its impact on its operations and financial performance. Discovering the Kumiai Chemical location and its key personnel will also be explored.
Who Founded Kumiai Chemical?
The story of Kumiai Chemical Industry Co., Ltd. begins with Ihara Agrochemical, established in Shizuoka Prefecture in 1949. Tracing the roots of Kumiai Chemical Company ownership, the company evolved through a merger in 1968 with Toa Agricultural Chemical Co., Ltd., adopting its current name.
While the exact details of the founders and initial ownership structure of Kumiai Chemical are not widely available, the company's early development was significantly shaped by its relationship with the National Federation of Agricultural Cooperative Associations (JA Zen-Noh).
This alliance provided a crucial distribution network and access to farmers across Japan, reflecting the company's initial focus on the agricultural sector. The company's vision was to contribute to a safe and secure society through its products, a goal that continues to influence its operations.
The early years of Kumiai Chemical were marked by a strategic focus on the agricultural market, leveraging a strong partnership to establish a solid foundation. The company's history is closely tied to the evolution of the agricultural industry in Japan.
- The merger in 1968 was a pivotal moment in the company's history, changing its name and setting the stage for future growth.
- The partnership with JA Zen-Noh has been a cornerstone of Kumiai Chemical's operations, providing a vital sales and distribution channel.
- The company's early vision was centered on contributing to a safe and prosperous society, particularly through its products designed for agricultural use.
- For more details on the company's target market, you can read about the Target Market of Kumiai Chemical.
Kumiai Chemical SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Kumiai Chemical’s Ownership Changed Over Time?
The ownership of Kumiai Chemical Industry Co., Ltd. has evolved over time, reflecting its status as a publicly traded company. Listed on the Prime Market of the Tokyo Stock Exchange (TSE: 4996), the company's ownership structure is characterized by a mix of institutional and individual investors. Key events impacting the ownership structure include the company's initial public offering and subsequent secondary offerings, which have broadened its shareholder base. The company's strategic partnerships and collaborations may also influence its ownership dynamics over time.
As of May 14, 2025, Kumiai Chemical had 58 institutional owners and shareholders, holding a total of 7,921,025 shares. This indicates a diverse ownership structure, with significant holdings by various investment funds. The company's financial performance, including net sales of ¥96,177 million and an operating profit of ¥9,442 million for the six months ended April 30, 2025, also plays a role in shaping investor confidence and ownership trends. Understanding the Growth Strategy of Kumiai Chemical can provide further insights into the company's future and potential impacts on its ownership.
| Shareholder | Type | Holding Details |
|---|---|---|
| Vanguard Total International Stock Index Fund Investor Shares (VGTSX) | Institutional | Major Shareholder |
| Vanguard Developed Markets Index Fund Admiral Shares (VTMGX) | Institutional | Major Shareholder |
| iShares Core MSCI EAFE ETF (IEFA) | Institutional | Major Shareholder |
Major institutional shareholders include Vanguard Total International Stock Index Fund Investor Shares (VGTSX), Vanguard Developed Markets Index Fund Admiral Shares (VTMGX), and iShares Core MSCI EAFE ETF (IEFA). Other notable institutional investors are Transamerica International Small Cap Value I (TISVX), DFA International Small Cap Value Portfolio - Institutional Class (DISVX), and Dimensional International Small Cap Value ETF (DISV). Additionally, Nippon Soda Co., Ltd., Nihon Nohyaku Co., Ltd., Nissan Chemical Corp., Sumitomo Chemical Co., Ltd., and Kaneka Corp. are among the major shareholders. The company's stock price on June 10, 2025, was $5.43, with a market cap of $654 million and 120 million shares.
Kumiai Chemical Company ownership is primarily composed of institutional investors and other major shareholders. The company is publicly listed on the Tokyo Stock Exchange, indicating a broad shareholder base.
- Institutional investors hold a significant portion of the shares.
- Key shareholders include various investment funds and other chemical companies.
- The company's market capitalization was approximately ¥98,092 million as of 2024.
- The stock price on June 10, 2025, was $5.43.
Kumiai Chemical PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Kumiai Chemical’s Board?
The corporate governance of Kumiai Chemical Industry Co., Ltd. is structured around an Audit & Supervisory Board. The company's operations involve a Board of Directors, Management Meetings, and Executive Meetings. The Board of Directors is primarily responsible for making decisions about management policies and overseeing business execution. Understanding Kumiai Chemical Company ownership structure requires examining the composition and roles of the board members.
As of January 29, 2025, the leadership includes Masaru Yokoyama as Representative Director and President. Other key figures are Takumi Yoshimura, Director and Senior Managing Executive Officer; Yu Yokoyama, Director, General Manager of Business Management, and Managing Executive Officer; Teruhiko Ikawa, Director and Managing Executive Officer, heading the Production and Procurement Division; Yoshihiro Yamaji and Kouichi Iwata, also Directors and Managing Executive Officers, leading the Corporate Planning & Coordination Division and Domestic Sales Division respectively. The board also includes Outside Directors such as Tadahisa Nishio and Kanji Ikeda, who serve as Independent Officers. For insights into the company's strategic direction, you might also find the Growth Strategy of Kumiai Chemical helpful.
| Board Member | Title | Role |
|---|---|---|
| Masaru Yokoyama | Representative Director and President | Leadership |
| Takumi Yoshimura | Director and Senior Managing Executive Officer | Executive Management |
| Yu Yokoyama | Director, General Manager of Business Management, and Managing Executive Officer | Executive Management |
| Teruhiko Ikawa | Director and Managing Executive Officer | Production and Procurement Division Head |
| Yoshihiro Yamaji | Director and Managing Executive Officer | Corporate Planning & Coordination Division Head |
| Kouichi Iwata | Director and Managing Executive Officer | Domestic Sales Division Head |
| Tadahisa Nishio | Outside Director | Independent Officer |
| Kanji Ikeda | Outside Director | Independent Officer |
The remuneration system for directors includes monetary rewards and transfer-restricted stock remuneration, excluding Outside Directors. This approach aims to align incentives with enhancing corporate value. While specific details on the voting power related to individual board members' shareholdings are not publicly available, the structure suggests a focus on long-term value creation. Information regarding recent proxy battles or activist investor campaigns is not available in the provided search results, offering a glimpse into Kumiai Chemical Company ownership details and governance practices.
The Board of Directors at Kumiai Chemical is responsible for key management decisions and business oversight.
- Masaru Yokoyama is the current President and Representative Director.
- The board includes both internal and external directors.
- Director compensation is designed to encourage value creation.
- There is no information available about recent governance controversies.
Kumiai Chemical Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Kumiai Chemical’s Ownership Landscape?
Recent developments at the company include a leadership change. Masaru Yokoyama became President and Representative Director on November 1, 2024. This change aims to enhance corporate value. The company is focusing on strengthening profitability and developing new products and technologies.
Financially, for the six months ending April 30, 2025, the company reported net sales of ¥96,177 million, a 9.2% increase year-on-year. Operating profit rose to ¥9,442 million, up 6.9% year-on-year. The company projects net sales of ¥159,300 million and a profit attributable to owners of parent of ¥10,900 million for the fiscal year ending October 31, 2025. This financial information provides insights into the current performance and future outlook of the company, crucial for understanding the Kumiai Chemical Company ownership and overall financial health.
| Key Financial Data (as of April 30, 2025) | Amount (in million ¥) | Change (YoY) |
|---|---|---|
| Net Sales | 96,177 | +9.2% |
| Operating Profit | 9,442 | +6.9% |
| Forecasted Net Sales (FY2025) | 159,300 | N/A |
| Forecasted Profit Attributable to Owners (FY2025) | 10,900 | N/A |
In terms of industry trends, the company is actively developing new agrochemicals, aiming for a new product every three years. It is also expanding its herbicide sales globally, particularly with 'Axeev.' Additionally, a subsidiary completed construction of a new plant for bismaleimides (BMIs) for semiconductors. These initiatives highlight the company's strategic focus on innovation and market expansion. Understanding these trends is vital for those interested in who owns Kumiai Chemical and its future direction. For more details, you can read about the Marketing Strategy of Kumiai Chemical.
Masaru Yokoyama became President in November 2024. This change is part of strategic initiatives. The goal is to enhance corporate value and strengthen profitability.
Net sales increased by 9.2% year-on-year. Operating profit also saw a rise of 6.9%. The company forecasts strong financial results for the fiscal year 2025.
Developing new agrochemicals is a priority. The company aims for new products every three years. Expansion of herbicide sales globally is also underway.
A subsidiary completed a new plant for BMIs. This indicates a move to strengthen production. This will help the company grow and develop further.
Kumiai Chemical Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Kumiai Chemical Company?
- What is Competitive Landscape of Kumiai Chemical Company?
- What is Growth Strategy and Future Prospects of Kumiai Chemical Company?
- How Does Kumiai Chemical Company Work?
- What is Sales and Marketing Strategy of Kumiai Chemical Company?
- What is Brief History of Kumiai Chemical Company?
- What is Customer Demographics and Target Market of Kumiai Chemical Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.